Drug excretion into breast milk - Overview

被引:113
作者
Ito, S [1 ]
Lee, A [1 ]
机构
[1] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Dept Pediat, Toronto, ON M5G 1X8, Canada
关键词
adherence; breastfeeding; drug effect; drug therapy; drug transfer; human milk; milk production; neonate;
D O I
10.1016/S0169-409X(03)00034-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Breastfeeding is the optimal form of infant feeding for the first months of an infant's life, and the majority of healthy women initiate breastfeeding after the birth of their infant. However, women on medication may default to formula feeding or not taking their drug therapy for fear of exposing their infant to the medication through the breast milk. Although the majority of medications are considered to be compatible with breastfeeding, cases of significant infant toxicity exist, suggesting a case by case risk assessment to be made before the mother initiates breastfeeding or drug therapy. Unfortunately, current clinical risk assessment is often compromised by the paucity of data, as studies in breastfeeding women and their infants are ethically difficult to conduct. Circumventing the ethical constraints, approaches have been proposed to estimate drug excretion into milk from physicochemical characteristics of the drug, which diffuses through the mammary gland epithelia. However, as our understanding on drug transfer mechanisms increases, it has become abundantly clear that carrier-mediated processes are involved with excretion of a number of drugs into milk. This article provides an overview of the benefits of breastfeeding, the effect of medication use during breastfeeding on maternal decisions and infant health, and factors determining infant exposure to medication through the breast milk. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:617 / 627
页数:11
相关论文
共 98 条
[1]   Transporter gene expression in lactating and nonlactating human mammary epithelial cells using real-time reverse transcription-polymerase chain reaction [J].
Alcorn, J ;
Lu, X ;
Moscow, JA ;
McNamara, PJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (02) :487-496
[2]  
American Academy of Pediatrics Committee on Drugs, 2001, Pediatrics, V108, P776
[3]  
Anderson JW, 1999, AM J CLIN NUTR, V70, P525
[4]  
ANDERSON PO, 1991, CLIN PHARMACY, V10, P594
[5]  
[Anonymous], 1988, STUD FAMILY PLANN, V19, P361, DOI 10.2307/1966630
[6]   PHARMACOKINETIC DISPOSITION AND PROTEIN-BINDING OF FUROSEMIDE IN NEWBORN-INFANTS [J].
ARANDA, JV ;
PEREZ, J ;
SITAR, DS ;
COLLINGE, J ;
PORTUGUEZMALAVASI, A ;
DUFFY, B ;
DUPONT, C .
JOURNAL OF PEDIATRICS, 1978, 93 (03) :507-511
[7]   DEVELOPMENTAL PATTERNS OF RENAL FUNCTIONAL MATURATION COMPARED IN HUMAN NEONATE [J].
ARANT, BS .
JOURNAL OF PEDIATRICS, 1978, 92 (05) :705-712
[8]   PREDICTION OF DRUG DISTRIBUTION INTO HUMAN-MILK FROM PHYSICOCHEMICAL CHARACTERISTICS [J].
ATKINSON, HC ;
BEGG, EJ .
CLINICAL PHARMACOKINETICS, 1990, 18 (02) :151-167
[9]   COSTS ASSOCIATED WITH OFFICE VISITS FOR DIARRHEA IN INFANTS AND TODDLERS [J].
AVENDANO, P ;
MATSON, DO ;
LONG, J ;
WHITNEY, S ;
MATSON, CC ;
PICKERING, LK .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (11) :897-902
[10]   The economic impact of breastfeeding [J].
Ball, TM ;
Bennett, DM .
PEDIATRIC CLINICS OF NORTH AMERICA, 2001, 48 (01) :253-+